3,675 Danaher Corporation $DHR Shares Bought by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Danaher Corporation (NYSE:DHR) by 4.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 94,949 shares of the conglomerate’s stock after purchasing an additional 3,675 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Danaher were worth $21,036,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the company. Bank of Stockton boosted its position in shares of Danaher by 6.4% during the 3rd quarter. Bank of Stockton now owns 6,797 shares of the conglomerate’s stock worth $1,506,000 after acquiring an additional 409 shares in the last quarter. CWA Asset Management Group LLC increased its holdings in shares of Danaher by 6.5% in the 3rd quarter. CWA Asset Management Group LLC now owns 2,095 shares of the conglomerate’s stock valued at $464,000 after acquiring an additional 128 shares during the last quarter. Smithbridge Asset Management Inc. DE increased its holdings in shares of Danaher by 240.2% in the 3rd quarter. Smithbridge Asset Management Inc. DE now owns 39,387 shares of the conglomerate’s stock valued at $8,726,000 after acquiring an additional 27,808 shares during the last quarter. Value Partners Investments Inc. raised its position in shares of Danaher by 11.5% during the 3rd quarter. Value Partners Investments Inc. now owns 11,608 shares of the conglomerate’s stock worth $2,576,000 after acquiring an additional 1,197 shares in the last quarter. Finally, Hidden Cove Wealth Management LLC raised its position in shares of Danaher by 4.9% during the 3rd quarter. Hidden Cove Wealth Management LLC now owns 1,217 shares of the conglomerate’s stock worth $270,000 after acquiring an additional 57 shares in the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Stifel Nicolaus decreased their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Wells Fargo & Company cut their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. TD Cowen upped their target price on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a report on Tuesday, October 13th. Finally, Morgan Stanley upped their target price on shares of Danaher from $220.00 to $240.00 and gave the company an “overweight” rating in a report on Monday, October 12th. Two research analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $235.41.

Danaher Stock Up 0.2%

DHR opened at $224.78 on Wednesday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market capitalization of $158.02 billion, a P/E ratio of 39.93, a price-to-earnings-growth ratio of 2.82 and a beta of 0.76. The business’s 50-day simple moving average is $214.70 and its 200-day simple moving average is $196.54.

Danaher (NYSE:DHR) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The business’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.77 EPS. Analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s payout ratio is currently 28.42%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.